乙胺在术后脑脊液泄漏预防中的使用:文献综述
Evan A Patel1, Anthony M Saad2, Peter Filip1
1Department of Otolaryngology-Head and Neck Surgery, Rush University Medical Center, Chicago, IL, 60612, United States of America.
American journal of otolaryngology
|May 1, 2025
概括
乙胺在预防手术后和创伤病例中脑脊液 (CSF) 泄漏方面表现有前途. 需要进一步的研究来标准化协议,并优化这种碳酸酶抑制剂的剂量.
科学领域:
- 神经外科 神经外科
- 药理学 药理学是指药理学的学科.
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 乙胺是一种利尿和碳酸酶抑制剂,可降低脑脊液 (CSF) 的产生.
- 它用于预防手术后的脑脊髓泄漏已经确立,但协议尚未明确.
- 本综述审查了阿西塔佐胺在预防术后和创伤性CSF泄漏方面的有效性.
研究的目的:
- 系统地审查关于阿扎胺用于预防手术后和创伤性脑脊液泄漏的文献.
- 为了阐明在这些临床环境中阿西塔佐胺的疗效和最佳使用.
主要方法:
- 按照PRISMA指南进行了系统审查.
- 在PubMed,SCOPUS和CINAHL的搜索中,到2023年7月,共发现了215个出版物.
- 选择了15个出版物进行主题分析.
主要成果:
- 十二篇文章证明了阿扎胺在降低神经外科和耳鼻喉科手术中手术后的脑脊液泄漏率方面的有效性.
- 六篇文章讨论了它在管理创伤性内高血压,最佳剂量和不良影响方面的作用.
结论:
- 乙醇胺显示出潜在的预防术后和某些创伤性CSF泄漏.
- 需要进一步的研究来建立标准化的方案,优化剂量,并评估长期结果和不良影响.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
275
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
275
Local Anesthetics: Clinical Application as Spinal Anesthesia
594
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
594
Antiepileptic Drugs: Potassium Channel Activators
151
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
151
Cerebrospinal Fluid
2.0K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
2.0K
Drug Delivery: Parenteral Route
450
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
450
Angle Closure Glaucoma: Treatment
454
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
454


